Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. L0CPDAPSLDFLYX5 (U.S. Pat. App. Mar. 4, 2022)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. L0CPDAPSLDFLYX5 (U.S. Pat. App. Mar. 4, 2022)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. L0CPDAPTLDFLYX5 (U.S. Pat. App. Mar. 4, 2022)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. L0CPDAPTLDFLYX5 (U.S. Pat. App. Mar. 4, 2022)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. L1C5S1GTXBLUEX0 (U.S. Pat. App. Mar. 29, 2022)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. L1C5S1GTXBLUEX0 (U.S. Pat. App. Mar. 29, 2022)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. L0CPDAPVLDFLYX5 (U.S. Pat. App. Mar. 4, 2022)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. L0CPDAPVLDFLYX5 (U.S. Pat. App. Mar. 4, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 231 (N.D.W.Va. Nov. 14, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 231 (N.D.W.Va. Nov. 14, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 229 (N.D.W.Va. Nov. 12, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 229 (N.D.W.Va. Nov. 12, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 93 (N.D.W.Va. Feb. 2, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 93 (N.D.W.Va. Feb. 2, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 87 (N.D.W.Va. Jan. 31, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 87 (N.D.W.Va. Jan. 31, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 86 (N.D.W.Va. Jan. 31, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 86 (N.D.W.Va. Jan. 31, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 20 (N.D.W.Va. Dec. 5, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 20 (N.D.W.Va. Dec. 5, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 1 (N.D.W.Va. Nov. 8, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 1 (N.D.W.Va. Nov. 8, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 185 (N.D.W.Va. May. 31, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 185 (N.D.W.Va. May. 31, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 183 (N.D.W.Va. May. 21, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 183 (N.D.W.Va. May. 21, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 59 (N.D.W.Va. Jan. 8, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 59 (N.D.W.Va. Jan. 8, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 51 (N.D.W.Va. Jan. 4, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 51 (N.D.W.Va. Jan. 4, 2024)
+ More Snippets